000 03641cam a2200385Ii 4500
988 _aSpringer_Medicine_2017
999 _c95810
_d95810
_x1
001 95810
003 ES-MaUEC
005 20230102112722.0
006 m o d
007 cr cnu|||unuuu
008 170417s2017 sz a o 000 0 eng d
020 _a3319535609
_q(electronic bk.)
020 _a9783319535609
_q(electronic bk.)
020 _z3319535587
020 _z9783319535586
_q(print)
040 _aN$T
_cN$T
_dGW5XE
_dEBLCP
_dN$T
_dYDX
_dOCLCF
_dUAB
_dESU
_dAZU
_dUPM
_dIOG
_dCOO
_dOTZ
_dVT2
_dOCLCQ
_dU3W
_dES-MaUEC
_bspa
050 4 _aRC280.L8
_b2017 EB
245 0 0 _aAsbestos and mesothelioma
_cJoseph R. Testa, editor.
264 1 _aCham, Switzerland
_bSpringer
_c2017.
300 _a1 recurso en línea (viii, 407 páginas)
_bilustraciones (algunas a color)
336 _aTexto
_btxt
_2rdacontent
337 _aelectrónico
_bc
_2rdamedia
338 _arecurso electrónico
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
490 0 _aCurrent cancer research
500 _aSpringerLink
505 0 _a1. Malignant Mesothelioma -- An Asbestos Legacy -- 2. Asbestos and Fibrous Erionite -- 3. Epidemiology of Mesothelioma -- 4. Malignant Pleural Mesothelioma: History, Controversy and Future of a Man-Made Epidemic -- 5. Communities at High Risk in the Third Wave of Mesothelioma -- 6. Mesothelioma Pathology -- 7. Asbestos-Induced Inflammation in Malignant Mesothelioma and Other Lung Diseases -- 8. Germline and Somatic Mutations in Human Mesothelioma and Lessons from Asbestos-Exposed Genetically Engineered Mouse Models -- 9. Gene Signature of Malignant Pleural Mesothelioma -- 10. Cell Signaling and Epigenetic Mechanisms in Mesothelioma -- 11. 3D Models of Mesothelioma in the Study of Mechanisms of Cell Survival -- 12. Biomarkers of Response to Asbestos Exposure -- 13. Surgery Approaches in Mesothelioma -- 14. Radiotherapy and Photodynamic Therapy for Malignant Pleural Mesothelioma -- 15. Standard Chemotherapy Options and Clinical Trials of Novel Agents for Mesothelioma -- 16. Immunotherapeutic Approaches to Mesothelioma -- 17. Challenges Facing Mesothelioma Patients and Their Families: Medical/Legal Intersections -- 18. The Patient's Experience of Malignant Mesothelioma.
520 3 _aThis volume is comprised of a multidisciplinary assessment of the interplay between asbestos and cancer as well as new research about the biology and treatment of malignant mesothelioma. Chapters on the various types of asbestos and other mineral fibers, epidemiology, history and future of asbestos-related diseases are included. Other reviews present new information about the role of asbestos-related inflammation and genetic factors, including the role of inherited mutations of BAP1, in mesothelioma causation, as well as recent research about gene signatures, cell signaling, and epigenetic mechanisms in asbestos-related diseases. Other chapters provide updates of novel disease biomarkers and prevention, mechanistic lesson from genetically engineered mouse and 3-D models of mesothelioma tumorigenesis and therapeutic resistance. Also included are up-to-date reviews of surgical, molecularly targeted chemotherapeutic, and immunotherapeutic approaches for mesothelioma as well as an overview of legal issues.
650 7 _aPulmones
_xCáncer
_2embne
_9168954
700 1 _aTesta, Joseph R.,
_eeditor literario
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=http://link.springer.com/10.1007/978-3-319-53560-9
_zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942 _2lcc
_cLE
998 _b02/2018
_dz
_e-
_zSI